Phase I/II study of bexarotene capsule (BSC-1) in patients with Cutaneous T-cell Lymphoma (CTCL).

Trial Profile

Phase I/II study of bexarotene capsule (BSC-1) in patients with Cutaneous T-cell Lymphoma (CTCL).

Completed
Phase of Trial: Phase I/II

Latest Information Update: 13 May 2016

At a glance

  • Drugs Bexarotene (Primary)
  • Indications Cutaneous T cell lymphoma
  • Focus Therapeutic Use
  • Sponsors Minophagen
  • Most Recent Events

    • 07 Apr 2016 Status changed from active, no longer recruiting to completed.
    • 18 Jun 2014 Planned End Date changed from 1 Mar 2014 to 27 Dec 2013 as reported by University Hospital Medical Information Network - Japan.
    • 18 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top